Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside

scientific article

Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1537-2995.2005.00616.X
P698PubMed publication ID16181400

P2093author name stringRobyn Yim
P2860cites workAssociation of Professors of Medicine. Ethical issues in clinical research: an issue for all internistsQ33998375
Policies on faculty conflicts of interest at US universitiesQ34072901
Donating spare embryos for embryonic stem-cell researchQ34987653
Stem cell plasticity: a new image of the bone marrow stem cellQ35051733
Advances in human stem cell researchQ35155076
The rise of litigation in human subjects researchQ35166353
Nuclear transplantation, embryonic stem cells, and the potential for cell therapyQ35179632
Stem cell plasticityQ35212265
Recipes for adult stem cell plasticity: fusion cuisine or readymade?Q35587398
Stem cell research: the facts, the myths and the promisesQ35591636
Stem cells: review and updateQ35626633
Gene therapy in the post-Gelsinger era.Q40616400
Regulation of somatic-cell therapy and gene therapy by the food and drug administrationQ40849088
Protecting research subjects--the crisis at Johns HopkinsQ43899726
Stricter regulation proposed for US gene-therapy trialsQ45868747
Gene and stem cell therapiesQ45874350
How cloning could change medicine.Q53372716
New head of Federal office clear on protecting human research participants.Q53512172
Stem cell research: obligations when religious values conflict with professional values.Q54733330
P433issue4 Suppl
P304page(s)144S-58S
P577publication date2005-10-01
P1433published inTransfusionQ15758500
P1476titleAdministrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside
P478volume45